RhumbLine Advisers’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-28,185
| Closed | -$52K | – | 2984 |
|
|
2017
Q1 | $52K | Buy |
28,185
+1,274
| +5% | +$2.35K | ﹤0.01% | 2821 |
|
|
2016
Q4 | $139K | Buy |
26,911
+2,093
| +8% | +$10.8K | ﹤0.01% | 2756 |
|
|
2016
Q3 | $138K | Sell |
24,818
-8,900
| -26% | -$49.5K | ﹤0.01% | 2761 |
|
|
2016
Q2 | $187K | Buy |
33,718
+15,333
| +83% | +$85K | ﹤0.01% | 2774 |
|
|
2016
Q1 | $81K | Buy |
18,385
+200
| +1% | +$881 | ﹤0.01% | 2926 |
|
|
2015
Q4 | $109K | Buy |
18,185
+4,130
| +29% | +$24.8K | ﹤0.01% | 2939 |
|
|
2015
Q3 | $110K | Buy |
14,055
+575
| +4% | +$4.5K | ﹤0.01% | 2932 |
|
|
2015
Q2 | $83K | Buy |
+13,480
| New | +$83K | ﹤0.01% | 3015 |
|